The European Union, in coordination with the European Health and Digital Executive Agency, has launched DISARM, a Horizon Europe Innovation Action project that brings together 28 partners from 12 countries, including 10 EU Member States, the UK, and Canada.
Scientists at The Wistar Institute have identified a mechanism behind the chemotherapy resistance that makes ovarian cancer so lethal. The researchers showed that chemotherapy triggers an inflammatory cascade that recruits immune cells into the tumor microenvironment, which ultimately function to protect the cancer from subsequent chemotherapy.
